Trials / Completed
CompletedNCT02724345
Postoperative Adjuvant TACE Treatment in CK18 Positive Patients
The Effect of Postoperative Adjuvant TACE Treatment in CK18 Positive Patients of Hepatocellular Carcinoma.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 320 (actual)
- Sponsor
- Eastern Hepatobiliary Surgery Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate and analyse the clinical effect and application value of postoperative adjuvant TACE treatment in patients with different expression levels of CK18 using randomized controlled study and provide evidence for the necessity of postoperative adjuvant TACE.
Conditions
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2015-06-01
- Completion
- 2015-12-01
- First posted
- 2016-03-31
- Last updated
- 2016-03-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02724345. Inclusion in this directory is not an endorsement.